K J Felice1, M L Grunnet. Show Affiliations » 1. Department of Neurology, University of Connecticut School of Medicine, Farmington 06030-1845, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Action PotentialsAnti-Dyskinesia Agents/therapeutic useBrain Neoplasms/diagnosisElectromyographyHandHumansInclusion Bodies/pathologyInclusion Bodies/ultrastructureLevodopaLipoma/diagnosisMagnetic Resonance ImagingMaleMicroscopy, ElectronMiddle AgedMuscle, Skeletal/pathologyMuscle, Skeletal/ultrastructureMyositis, Inclusion Body/complicationsMyositis, Inclusion Body/pathologyMyositis, Inclusion Body/physiopathologyPropranolol/therapeutic useTremor/complicationsTremor/drug therapyTremor/physiopathologyTrihexyphenidyl/therapeutic useVacuoles/pathologyVacuoles/ultrastructure
Substances： See more » Anti-Dyskinesia AgentsLevodopaTrihexyphenidylPropranolol
Year: 1996 PMID： 8609934 DOI： 10.1002/(SICI)1097-4598(199606)19:6<787::AID-MUS18>3.0.CO;2-I
Source DB: PubMed Journal: Muscle Nerve ISSN： 0148-639X Impact factor: 3.217